# Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder

> **NCT05772104** · PHASE3 · RECRUITING · sponsor: **Sichuan Jishengtang Pharmaceutical Co., Ltd.** · enrollment: 495 (estimated)

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **DRUG:** Shugan Jieyu Capsules
- **DRUG:** Shugan Jieyu Capsules Placebo

## Key facts

- **NCT ID:** NCT05772104
- **Lead sponsor:** Sichuan Jishengtang Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-17
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-06-01
- **Target enrollment:** 495 (ESTIMATED)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05772104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05772104, "Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05772104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*